Outcome prediction to erlotinib in gastroesophageal adenocarcinomas: Can we improve epidermal growth factor receptor and phospho-AKT testing? [4]

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)910
Number of pages1
JournalJournal of Clinical Oncology
Volume25
Issue number7
DOIs
Publication statusPublished - Mar 1 2007

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this